Compare SGHT & DOMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SGHT | DOMO |
|---|---|---|
| Founded | 2011 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 187.4M | 189.3M |
| IPO Year | 2021 | 2018 |
| Metric | SGHT | DOMO |
|---|---|---|
| Price | $3.52 | $2.91 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 10 |
| Target Price | $9.08 | ★ $11.15 |
| AVG Volume (30 Days) | 368.5K | ★ 1.7M |
| Earning Date | 05-07-2026 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 28.16 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $77,363,000.00 | ★ $317,044,000.00 |
| Revenue This Year | $11.81 | $3.38 |
| Revenue Next Year | $10.62 | $4.74 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.03 | $2.84 |
| 52 Week High | $9.24 | $18.49 |
| Indicator | SGHT | DOMO |
|---|---|---|
| Relative Strength Index (RSI) | 35.25 | 32.97 |
| Support Level | $3.29 | N/A |
| Resistance Level | $3.76 | $5.39 |
| Average True Range (ATR) | 0.22 | 0.31 |
| MACD | 0.06 | -0.04 |
| Stochastic Oscillator | 11.43 | 9.85 |
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.
Domo Inc provides a cloud-based platform that digitally connects all the data, systems, and people in an organization, giving them access to real-time data and insights and allowing them to manage their business from their smartphones. The company offers a platform to its customers as a subscription-based service. Users receive notifications on any device and immediately act on the invitation, after which the system can write back to the original system of record. The company derives revenue from subscriptions to its cloud-based platform and professional services.